Vai al contenuto Visiting from the US? Discover Helixafe, our Cancer Driver Interception program →

Intercettazione dei driver del cancro

Conservazione cellule staminali

Sangue cordonale e tessuto adiposo

Longevità in salute

Cellule staminali ed esosomi

Genomica prenatale e neonatale

NGTX

Integratori alimentari

Genomica prenatale e neonatale

Studi Clinici

Test Prenatale non Invasivo

Come ottenerlo

Richiedi il test

Scrivici su WhatsApp Acquista nello shop online Chiedi agli esperti

2011 January Non-invasive prenatal assessment oftrisomy 21 by multiplexed maternalplasma DNA sequencing: large scalevalidity study. To validate the clinical efficacy and practical feasibility of massively parallel maternal plasma DNA sequencing to screen for fetal trisomy 21 among high risk pregnancies clinically indicated for amniocentesis or chorionic villus sampling. LEGGI

2011 June Noninvasive Prenatal Diagnosis of Fetal Trisomy18 and Trisomy 13 by Maternal Plasma DNASequencing Massively parallel sequencing of DNA molecules in the plasma of pregnant women has been shown to allow accurate and noninvasive prenatal detection of fetal trisomy 21. LEGGI

2012 April Clinical utility of noninvasive fetal trisomy (NIFTY)test – early experience. To report the initial experience of noninvasive prenatal diagnosis of fetal Down syndrome (The NIFTY test) in a clinical setting. Methods: The NIFTY test was offered as a screening test for fetal Down syndrome to pregnant women with a singleton pregnancy at 12 weeks of gestation or beyond. LEGGI

2012 August Noninvasive prenatal diagnosis ofcommon fetal chromosomal aneuploidiesby maternal plasma DNA sequencing. To develop a new bioinformatic method in the noninvasive prenatal identification of common fetal aneuploidies using massively parallel sequencing on maternal plasma. LEGGI

2012 December Clinical application of massively parallel sequencing-based prenatal noninvasivefetal trisomy test for trisomies 21 and18 in 11,105 pregnancies with mixedrisk factors. To report the performance of massively parallel sequencing (MPS) based prenatal noninvasive fetal trisomy test based on cell-free DNA sequencing from maternal plasma in a routine clinical setting in China. LEGGI

2012 December Prenatal detection of aneuploidy and imbalanced chromosomal arrangementsby massively parallel sequencing. Fetal chromosomal abnormalities are the most common reasons for invasive prenatal testing. LEGGI

2012 December Noninvasive Fetal Trisomy (NIFTY) test: an advanced noninvasive prenatal diagnosis methodology for fetal autosomal and sex chromosomal aneuploidies Conventional prenatal screening tests, such as maternal serum tests and ultrasound scan, have limited resolution and accuracy. LEGGI

2013 March Non-invasive prenatal screening of fetal Down syndrome by maternal plasma DNA sequencing intwin pregnancies. Non-invasive prenatal screening for fetal Down syndrome (NIFTY) by maternal plasma sequencing was performed in 12 subjects with twin pregnancies, including 11 with normal fetuses and 1 with discordant fetal Trisomy 21. LEGGI

2013 May Feasibility study of semiconductor sequencing for noninvasive prenatal detection of fetal aneuploidy. Noninvasive prenatal detection of common fetal aneuploidies with cell-free DNA from maternal plasma has been achieved with high-throughput next-generation sequencing platforms. LEGGI

2013 June Discordant results between fetalkaryotyping and non-invasive prenataltesting by maternal plasma sequencingin a case of uniparental disomy 21 due totrisomic rescue. Uniparental disomy (UPD) is an uncommon chromosome condition, but UPD involving chromosome 21 is rarely reported. LEGGI

2013 June Secondary findings from non-invasive prenataltesting for common fetal aneuploidies bywhole genomesequencing as a clinical service. To report secondary or additional findings arising from introduction of non-invasive prenatal testing (NIPT) for aneuploidy by whole genome sequencing as a clinical service. LEGGI

2013 June Effective Noninvasive ZygosityDetermination by Maternal Plasma TargetRegion Sequencing Currently very few noninvasive molecular genetic approaches are available to determine zygosity for twin pregnancies in clinical laboratories. LEGGI

2013 June A method for noninvasive detection of fetal large deletions/duplications by lowcoverage massively parallel sequencing. To report the feasibility of fetal chromosomal deletion/duplication detection using a novel bioinformatic method of low coverage whole genome sequencing of maternal plasma. LEGGI

2014 April Noninvasive prenatal testing of trisomies 21 and18 by massively parallel sequencing of maternalplasma DNA in twin pregnancies. The objective of this study is to assess the performance of noninvasive prenatal testing for trisomies 21 and 18 on the basis of massively parallel sequencing of cell-free DNA from maternal plasma in twin pregnancies. LEGGI

2014 September Genetic effects of a 13q31.1 microdeletiondetected by noninvasive prenatal testing (NIPT). Microdeletions of chromosome 13q31.1 are relatively rare. These types of deletions may cause different genetic effects on genotypes and/or phenotypes. LEGGI

2015 May Non-invasive prenatal testing for trisomies21, 18 and 13: clinical experience from146,958 pregnancies. To report the clinical performance of massively parallel sequencing-based non-invasive prenatal testing (NIPT) in detecting trisomies 21, 18 and 13 in over 140,000 clinical samples and to compare its performance in low-risk and high-risk pregnancies. acid LEGGI

Contenuti scientifici revisionati dal Comitato Scientifico di Bioscience Institute. · Ultimo aggiornamento 2025-05-05

Le informazioni in questa pagina hanno scopo divulgativo e non sostituiscono il consulto con un medico.

Questa pagina in altre lingue: English 中文

Genomica prenatale e neonatale

Richiedi informazioni

Raccontaci la tua situazione: uno specialista di quest'area ti ricontatterà, nel tuo paese e nella tua lingua.

Lo screening prenatale stima un rischio; un risultato positivo va confermato con un test diagnostico prescritto dal ginecologo.

Preferisci WhatsApp? Scrivici su WhatsApp

Nome Cognome Email PrefissoTelefono Paese Città EtàIl tuo messaggio Ho letto l'informativa sulla privacy e autorizzo il trattamento dei miei dati.

Genomica prenatale e neonatale

Screening prenatale non invasivo dalla decima settimana, screening dei portatori per i genitori e screening esteso per i neonati.

Screening prenatale non invasivo dalla decima settimana, validato su 112.669 gravidanze, con screening dei portatori per i genitori e screening esteso per i neonati nei primi giorni di vita.

Richiedi il test Scopri ULTRANIPT